Our News
MELBOURNE, Fla. – Preeclampsia is a life-threatening hypertensive disorder affecting 300,000 pregnant women in the U.S. annually, often yielding serious complications for mother and baby as well as long-term effects. Eleni Z. Tsigas is devoti...
April 30, 2022 - Melbourne, FL – Preeclampsia, a hypertensive disorder of pregnancy, is a leading cause of premature birth and a major contributor to adverse maternal outcomes and maternal death. This May, the Preeclampsia Foundation, a US-ba...
Effects of Supervised Exercise on the Development of Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis Exercise is recommended to support a healthy pregnancy when determined safe by a patient’s healthcare provider Rese...
SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality Early in the COVID-19 pandemic, there were reports of worse COVID-19 disease in pregnant persons compare...
Microvascular Outcomes in Women With a History of Hypertension in Pregnancy Having had preeclampsia increases a person’s risk for cardiovascular disease in later life. However, how preeclampsia and cardiovascular disease become linked is not y...
The Preeclampsia Registry in Action: Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia Category: Risk Lay Summary: One clinical risk factors for developing preeclampsia in pregnancy is having had preeclamp...
Blood pressure at the beginning of pregnancy linked to risk for preeclampsia, especially among Black, Asian, and Hispanic persons As pregnancy progresses, maternal blood pressure changes. In a pregnancy without high blood pressure, blood pressure is...
March 8, 2022 – Melbourne, FL – A study published in BMJ Open describes the Patient Journey as it relates to awareness, communication, and involvement with decision making during experiences with preeclampsia, a potentially life-threateni...
Orlando, FL – February 2, 2022 – The Preeclampsia Foundation announced today the recipients of its 2022 Peter Joseph Pappas Research Grants at the Society for Maternal Fetal Medicine 42nd Annual Pregnancy Meeting. Based on the recommendat...
Orlando, FL – February 2, 2022 – The Preeclampsia Foundation announced today at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Meeting – The Pregnancy Meeting™ – that applications are now being accept...
The Preeclampsia Foundation announced today that Merck for Mothers has awarded new funding for its program, MoMMA’s Voices, a national coalition of patient advocacy organizations and individuals with "lived experience" – or those that...
Dear friends, As this new year starts and I step into the role of Chairperson of the Foundation’s Board of Directors, I realize that “business as normal” has completely changed in the face of the COVID pandemic. The past two years...
Related Articles
Donating appreciated securities, including stocks or bonds, is an easy and tax-effective way for you to make a gift to the Preeclampsia Foundation.
PUBLIC POLICY PRIORITIES The Preeclampsia Foundation's advocacy priorities are focused on supporting efforts to reduce maternal and infant illness and death due to preeclampsia, HELLP syndrome, a...
We did it! Act2SaveMoms has become a law December 22, 2018: This is a great day for preeclampsia and the beginning of the end of needless deaths. Late last night, President Trump...
Want to impact how your state and our nation handles maternity care?
RECOGNITION & RESPONSE IS CRITICAL Less than half of well-educated women know the signs and symptoms of preeclampsia. And still others may not share their symptoms with their healthcare pro...